The voice of passengers: these are the best airports for customer experience, ACI World reveals
The 2025 ASQ Customer Experience Awards show airports outperforming other industries as…
LIXIL Reaches Major Milestone in Impact Strategy, Improving Sanitation and Hygiene for 103 Million People Globally
TOKYO, Feb. 23, 2026 /PRNewswire/ -- LIXIL Corporation ("LIXIL", TSE Code: 5938),…
Cholan Tours Breaks Industry Barriers with India’s First Women Chauffeur-Driven Tours
CHENNAI, India, Feb. 24, 2026 /PRNewswire/ -- One of the most reputable destination…
SPJIMR’s TaSIC 2026 catalyses dialogue on responsible growth
Global scholars and industry leaders co-create actionable pathways for India's sustainable, aspiration-led…
Medical Value Travel (MVT) acts as channel of cooperation that builds confidence, strengthens people-to-people ties between nation
Integrated care model with advanced clinical excellence with Ayush is strengthening India's…
Institutional Mental Health Strengthens Across 62 Colleges as Women Emerge as Key Peer Support Leaders
MUMBAI, India, Feb. 23, 2026 /PRNewswire/ -- A year-long youth mental health…
More than 100 C-suite Retail Leaders to Speak at NRF 2026 APAC
SINGAPORE, Feb. 24, 2026 /PRNewswire/ -- The National Retail Federation and global…
Supernus Pharmaceuticals to Participate in March Investor Conferences
February 23, 2026 18:15 ET | Source: Supernus Pharmaceuticals, Inc. ROCKVILLE, Md.,…
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
ROCKVILLE, MD, Feb. 23, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX),…
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
February 23, 2026 17:10 ET | Source: Kyntra Bio FG-3246 and enzalutamide…
